境内上市外资股转换上市地以介绍方式在香港联合交易所有限公司主板上市及挂牌交易方案（英文版）.docVIP

境内上市外资股转换上市地以介绍方式在香港联合交易所有限公司主板上市及挂牌交易方案(英文版) Stock code:, Stock abbreviation: Livzon Group, Livzon B Listing place: Shenzhen Stock Exchange LivzonPharmaceuticalGroupInc., ListingLocationChangeandListingTradingofDomestically ListedForeignSharesby wayofIntroductionontheMain Board oftheStock ExchangeofHongKongLimited Financialconsultant No. 1012, Hongling Middle Road, Floor 16-26, GUOSEN Building, Shenzhen City January,2013Statement The company as well as all members of its Board of Directors hereby ensure that this announcement is factual, accurate and complete without any false information, misleading statement or material omission, and take the joint and several legal liabilities. Corporate director, leading members of accounting work as well as the accounting body ensure that this proposal contains a factual, accurate and complete the financial statement. Any decision or opinion made by China Securities Regulatory Commission as well as other government agency, institution never contains the material judgment or guarantee, and any announcement on the contrary to the same herein will be of misleading statement. After it is completed for Listing Location Change of of Domestically Listed Foreign Shares B-share, Such H-share of Listing Location Change is applicable to listing, trading, settlement and other rules in Hong Kong, no longer applicable to listing, trading and other relevant rules in Shenzhen Stock Exchange and also not applicable to registration settlement rules of Chinese clearing corporation and other relevant rules. Relevant rules applicable to RMB Ordinary Share A-share in the companyremain unchanged. After completion of this proposal, the change of corporate management and earnings are the sole responsibilities for the company; any investment risk arising from this proposal is the sole responsibility for investor. For any doubt to be found by an investor in this proposal, it is suggested to inquiry your own stock broker, lawyer,